{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:33:00Z","timestamp":1764858780912},"reference-count":38,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T00:00:00Z","timestamp":1412985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T00:00:00Z","timestamp":1412985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":473,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kjms-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Kaohsiung J of Med Scie"],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label \/><jats:p>The prevalence rate of metabolic syndrome (MS) and coronary artery disease (CAD) has been found to be high in patients with chronic schizophrenia. Current evidence shows that CAD is underdiagnosed in this group. Our study evaluated the prevalence of MS and the risk of CAD in patients with chronic schizophrenia in a chronic care mental hospital in southern Taiwan. We included all patients with the diagnosis of schizophrenia or schizoaffective disorder. We collected all laboratory, physical examination, psychiatric interview, and chart review data. We also evaluated the risk of CAD in these patients using the Framingham point system. There was no significant age difference in the MS prevalence rate in these patients. The young patients with schizophrenia in our study tended to have a higher prevalence of MS than the general population. In addition, female patients had a higher prevalence rate of MS than males. Based on the Framingham point system, we found the 10\u2010year risk of CAD to be higher among the patients with schizophrenia than in the general population. Our study highlights the importance of the high risk of MS in both younger and older patients with schizophrenia, without a significant relationship to the use of antipsychotics. More complete cohort studies are needed to confirm these findings. Psychiatrists may want to establish more specific and detailed clinical guidelines for patients with chronic schizophrenia with comorbid physical diseases, especially MS and CAD.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.kjms.2014.09.002","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T04:40:19Z","timestamp":1413002419000},"page":"579-586","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The metabolic syndrome and risk of coronary artery disease in patients with chronic schizophrenia or schizoaffective disorder in a chronic mental institute"],"prefix":"10.1002","volume":"30","author":[{"given":"Ping\u2010Tao","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung\u2010Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2010Shian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng\u2010Chih","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pao\u2010Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching\u2010Kuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(09)60161-3"},{"key":"e_1_2_6_3_2","unstructured":"C.J.Chen C.H.Po S.L.Yu K.L.Chien C.H.Tseng T.C.Su.The surveillance for prevalence rate of hypertension hyperglycemia and hyperlipidemia in Taiwan.2008"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7176.119471"},{"key":"e_1_2_6_5_2","first-page":"15S","article-title":"Metabolic issues and cardiovascular disease in patients with psychiatric disorders","volume":"118","author":"Casey D.E.","year":"2005","journal-title":"Am J Med"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.12.1775"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200202000-00007"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.07.014"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.2.242"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.1.31"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0402"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674370605100803"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","unstructured":"Y.vonHausswolff\u2010Juhlin M.Bjartveit E.Lindstrom P.Jones.Schizophrenia and physical health problems.Acta Psychiatr Scand Suppl.2009;15\u201321","DOI":"10.1111\/j.1600-0447.2008.01309.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.031716"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2004.01.014"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.08.010"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033504"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.284"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0408"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.104.008060"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.2.180"},{"key":"e_1_2_6_23_2","first-page":"143","article-title":"New advance in risk prognostication for coronary event","volume":"17","author":"Kang C.S.","year":"2006","journal-title":"J Intern Med Taiwan"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2005.044842"},{"key":"e_1_2_6_25_2","unstructured":"The Health Promotion Administration of Taiwan.Metabolic syndrome definition in Taiwan Taiwan.2006 edition.2006 Url:http:\/\/www.hpa.gov.tw\/manual\/common\/\u4ee3\u8b1d\u75c7\u5019\u7fa4\u9632\u6cbb\u5de5\u4f5c\u624b\u518a\/002.pdf"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/08039488.2011.621977"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-010-0118-x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.08.030"},{"key":"e_1_2_6_29_2","first-page":"20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence","volume":"68","author":"Newcomer J.W.","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_30_2","first-page":"S38","article-title":"Pharmcoeconomic impact of antipsychotic induced metabolic events","volume":"3","author":"L'Italien G.J.","year":"2003","journal-title":"Prev Med Manag Care"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0269881113516200","article-title":"Endothelial nitric oxide synthetase genetic variants, metabolic syndrome and endothelial function in schizophrenia","volume":"28","author":"Burghardt K.","year":"2014","journal-title":"J Psychopharmacol"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000355632"},{"key":"e_1_2_6_33_2","first-page":"51","article-title":"Association of erythrocyte sedimentation rate and fibrinogen concentration with metabolic syndrome in schizophrenic patients","volume":"25","author":"Pavlovic M.","year":"2013","journal-title":"Psychiatr Danub"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01401.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674370404901106"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.05.009"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2013.06.020"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.11.029"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-11-201312030-00008"}],"container-title":["The Kaohsiung Journal of Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1607551X14001806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1607551X14001806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.kjms.2014.09.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T04:23:38Z","timestamp":1694665418000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1016\/j.kjms.2014.09.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1016\/j.kjms.2014.09.002"],"URL":"https:\/\/doi.org\/10.1016\/j.kjms.2014.09.002","archive":["Portico"],"relation":{},"ISSN":["1607-551X","2410-8650"],"issn-type":[{"value":"1607-551X","type":"print"},{"value":"2410-8650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The metabolic syndrome and risk of coronary artery disease in patients with chronic schizophrenia or schizoaffective disorder in a chronic mental institute","name":"articletitle","label":"Article Title"},{"value":"The Kaohsiung Journal of Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kjms.2014.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}